ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
2001 ◽
Vol 94
(6)
◽
pp. 774-782
◽
2006 ◽
Vol 282
(5)
◽
pp. 2840-2850
◽
2005 ◽
Vol 11
(19)
◽
pp. 7080s-7086s
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2007 ◽
Vol 98
(12)
◽
pp. 1977-1984
◽
2015 ◽
Vol 16
(6)
◽
pp. e259-e261
◽
2008 ◽
Vol 99
(8)
◽
pp. 1611-1617
◽